pd 123177 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, CA; Schambelan, M; Sechi, LA | 1 |
| Naitoh, T; Shikada, K; Tanaka, S; Yotsumoto, T | 1 |
2 other study(ies) available for pd 123177 and Alloxan Diabetes
| Article | Year |
|---|---|
The cardiac renin-angiotensin system in STZ-induced diabetes.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Gene Expression; Hyperglycemia; Imidazoles; Insulin; Kinetics; Losartan; Male; Myocardium; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Renin-Angiotensin System; RNA, Messenger; Tetrazoles | 1994 |
Effects of specific antagonists of angiotensin II receptors and captopril on diabetic nephropathy in mice.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertrophy; Imidazoles; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred Strains; Pyridines; Receptors, Angiotensin; Streptozocin | 1997 |